Plasticity of macrophage function during tumor progression: Regulation by distinct molecular mechanisms

Journal of Immunology

Volumn 180, Issue 4, 2008, Pages 2011-2017

  Biswas, Subhra K ^a   Sica, Antonio ^b   Lewis, Claire E ^c  

^a AGENCY FOR SCIENCE   (Singapore)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; PHOSPHOTRANSFERASE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1;

HUMAN; HYPOXIA; MACROPHAGE FUNCTION; MOLECULAR DYNAMICS; NONHUMAN; PHENOTYPE; PLASTICITY; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; ANIMAL; CLASSIFICATION; DISEASE COURSE; IMMUNOLOGY; IMMUNOPHENOTYPING; MACROPHAGE; METABOLISM; NEOPLASM; PATHOLOGY;

ANIMALS; DISEASE PROGRESSION; HUMANS; IMMUNOPHENOTYPING; MACROPHAGES; NEOPLASMS;

EID: 42149099408     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.4.2011     Document Type: Review

References (60)

1. Lin, W. W., and M. Karin. 2007. A cytokine-mediated link between innate immunity, inflammation, and cancer. J. Clin. Invest. 117: 1175-1183.
2. Li, Q., S. Withoff, and I. M. Verma. 2005. Inflammation-associated cancer: NF-κB is the lynchpin. Trends Immunol. 26: 318-325.
3. Balkwill, F., K. A. Charles, and A. Mantovani. 2005. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7: 211-217.
4. Pollard, J. W. 2004. Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer 4: 71-78.
5. Lin, E. Y., A. V. Nguyen, R. G. Russell, and J. W. Pollard. 2001. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J. Exp. Med. 193: 727-740.
6. Lin, E. Y., J. F. Li, L. Gnatovskiy, Y. Deng, L. Zhu, D. A. Grzesik, H. Qian, X. N. Xue, and J. W. Pollard. 2006. Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res. 66: 11238-11246.
7. Mantovani, A., A. Sica, S. Sozzani, P. Allavena, A. Vecchi, and M. Locati. 2004. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25: 677-686.
8. Mantovani, A., S. Sozzani, M. Locati, P. Allavena, and A. Sica. 2002. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23: 549-555.
9. Biswas, S. K., L. Gangi, S. Paul, T. Schioppa, A. Saccani, M. Sironi, B. Bottazzi, A. Doni, B. Vincenzo, F. Pasqualini, et al. 2006. A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-κB and enhanced IRF-3/STAT1 activation). Blood 107: 2112-2122.
10. Saccani, A., T. Schioppa, C. Porta, S. K. Biswas, M. Nebuloni, L. Vago, B. Bottazzi, M. P. Colombo, A. Mantovani, and A. Sica. 2006. p50 nuclear factor-κB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance. Cancer Res. 66: 11432-11440.
11. Coussens, L. M., and Z. Werb. 2002. Inflammation and cancer. Nature 420: 860-867.
12. Karin, M., T. Lawrence, and V. Nizet. 2006. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell. 124: 823-835.
13. Karin, M., and F. R. Greten. 2005. NF-κB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 5: 749-759.
14. Greten, F. R., L. Eckmann, T. F. Greten, J. M. Park, Z. W. Li, L. J. Egan, M. F. Kagnoff, and M. Karin. 2004. IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell. 118: 285-296.
15. Maeda, S., H. Kamata, J. L. Luo, H. Leffert, and M. Karin. 2005. IKKβ couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 121: 977-990.
16. Pikarsky, E., R. M. Porat, I. Stein, R. Abramovitch, S. Amit, S. Kasem, E. Gutkovich-Pyest, S. Urieli-Shoval, E. Galun, and Y. Ben-Neriah. 2004. NF-κB functions as a tumour promoter in inflammation-associated cancer. Nature 431: 461-466.
17. Zitvogel, L., A. Tesniere, and G. Kroemer. 2006. Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat. Rev. Immunol. 6: 715-727.
18. Dinapoli, M. R., C. L. Calderon, and D. M. Lopez. 1996. The altered tumoricidal capacity of macrophages isolated from tumor-bearing mice is related to reduce expression of the inducible nitric oxide synthase gene. J. Exp. Med. 183: 1323-1329.
19. Sica, A., A. Saccani, B. Bottazzi, N. Polentarutti, A. Vecchi, J. van Damme, and A. Mantovani. 2000. Autocrine production of IL-10 mediates defective IL-12 production and NF-κ B activation in tumor-associated macrophages. J. Immunol. 164: 762-767.
20. Ghassabeh, G. H., P. De Baetselier, L. Brys, W. Noel, J. A. Van Ginderachter, S. Meerschaut, A. Beschin, F. Brombacher, and G. Raes. 2006. Identification of a common gene signature for type II cytokine-associated myeloid cells elicited in vivo in different pathologic conditions. Blood. 108: 575-583.
21. Wagner, S., S. Czub, M. Greif, G. H. Vince, N. Suss, S. Kerkau, P. Rieckmann, W. Roggendorf, K. Roosen, and J. C. Tonn. 1999. Microglial/macrophage expression of interleukin 10 in human glioblastomas. Int. J. Cancer. 82: 12-16.
22. Lewis, C. E., and J. W. Pollard. 2006. Distinct role of macrophages in different tumor microenvironments. Cancer Res. 66: 605-612.
23. Zeisberger, S. M., B. Odermatt, C. Marty, A. H. Zehnder-Fjallman, K. Ballmer-Hofer, and R. A. Schwendener. 2006. Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach. Br. J. Cancer. 95: 272-281.
24. De Palma, M., M. A. Venneri, R. Galli, L. Sergi Sergi, L. S. Politi, M. Sampaolesi, and L. Naldini. 2005. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 8: 211-226.
25. Venneri, M. A., M. De Palma, M. Ponzoni, F. Pucci, C. Scielzo, E. Zonari, R. Mazzieri, C. Doglioni, and L. Naldini. 2007. Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer. Blood. 109: 5276-5285.
26. Murdoch, C., M. Muthana, and C. E. Lewis. 2005. Hypoxia regulates macrophage functions in inflammation. J. Immunol. 175: 6257-6263.
27. Leek, R. D., C. E. Lewis, R. Whitehouse, M. Greenall, J. Clarke, and A. L. Harris. 1996. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res. 56: 4625-4629.
28. Ohno, S., Y. Ohno, N. Suzuki, T. Kamei, K. Koike, H. Inagawa, C. Kohchi, G. Soma, and M. Inoue. 2004. Correlation of histological localization of tumor-associated macrophages with clinicopathological features in endometrial cancer. Anticancer Res. 24: 3335-3342.
29. Sica, A., and V. Bronte. 2007. Altered macrophage differentiation and immune dysfunction in tumor development. J. Clin. Invest. 117: 1155-1166.
30. Kusmartsev, S., and D. I. Gabrilovich. 2005. STAT1 signaling regulates tumor-associated macrophage-mediated T cell deletion. J. Immunol. 174: 4880-4891.
31. Tsai, C. S., F. H. Chen, C. C. Wang, H. L. Huang, S. M. Jung, C. J. Wu, C. C. Lee, W. H. McBride, C. S. Chiang, and J. H. Hong. 2007. Macrophages from irradiated tumors express higher levels of iNOS, arginase-I and COX-2, and promote tumor growth. Int. J. Radiat. Oncol. Biol. Phys. 68: 499-507.
32. Sugai, H., K. Kono, A. Takahashi, F. Ichihara, H. Kawaida, H. Fujii, and Y. Matsumoto. 2004. Characteristic alteration of monocytes with increased intracellular IL-10 and IL-12 in patients with advanced-stage gastric cancer. J. Surg. Res. 116: 277-287.
33. Hagemann, T., J. Wilson, F. Burke, H. Kulbe, N. F. Li, A. Pluddemann, K. Charles, S. Gordon, and F. R. Balkwill. 2006. Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype. J. Immunol. 176: 5023-5032.
34. Auffray, C., D. Fogg, M. Garfa, G. Elain, O. Join-Lambert, S. Kayal, S. Sarnacki, A. Cumano, G. Lauvau, and F. Geissmann. 2007. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 317: 666-670.
35. Luedde, T., N. Beraza, V. Kotsikoris, G. van Loo, A. Nenci, R. De Vos, T. Roskams, C. Trautwein, and M. Pasparakis. 2007. Deletion of NEMO/IKKγ in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma. Cancer Cell. 11: 119-132.
36. Barker, R. N., L. Erwig, W. P. Pearce, A. Devine, and A. J. Rees. 1999. Differential effects of necrotic or apoptotic cell uptake on antigen presentation by macrophages. Pathobiology 67: 302-305.
37. Biswas, S. K., and V. Tergaonkar. 2007. Myeloid differentiation factor 88-independent Toll-like receptor pathway: sustaining inflammation or promoting tolerance. Int. J. Biochem. Cell Biol. 39: 1582-1592.
38. Oshima, H., M. Oshima, K. Inaba, and M. M. Taketo. 2004. Hyperplastic gastric tumors induced by activated macrophages in COX-2/mPGES-1 transgenic mice. EMBO J. 23: 1669-1678.
39. He, W., Q. Liu, L. Wang, W. Chen, N. Li, and X. Cao. 2007. TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance. Mol. Immunol. 44: 2850-2859.
40. Huang, B., J. Zhao, S. Shen, H. Li, K. L. He, G. X. Shen, L. Mayer, J. Unkeless, D. Li, Y. Yuan, et al. 2007. Listeria monocytogenes promotes tumor growth via tumor cell Toll-like receptor 2 signaling. Cancer Res. 67: 4346-4352.
41. Kuang, D. M., Y. Wu, N. Chen, J. Cheng, S. M. Zhuang, and L. Zheng. 2007. Tumor-derived hyaluronan induces formation of immunosuppressive macrophages through transient early activation of monocytes Blood. 110: 587-595.
42. Tsan, M. F., and B. Gao. 2004. Endogenous ligands of Toll-like receptors. J. Leukocyte Biol. 76: 514-519.
43. Dillon, S., A. Agrawal, T. Van Dyke, G. Landreth, L. McCauley, A. Koh, C. Maliszewski, S. Akira, and B. Pulendran. 2004. A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells. J. Immunol. 172: 4733-4743.
44. Banerjee, A., R. Gugasyan, M. McMahon, and S. Gerondakis. 2006. Diverse Toll-like receptors utilize Tpl2 to activate extracellular signal-regulated kinase (ERK) in hemopoietic cells. Proc. Natl. Acad. Sci. USA 103: 3274-3279.
45. Tassiulas, I., K. H. Park-Min, Y. Hu, L. Kellerman, D. Mevorach, and L. B. Ivashkiv. 2007. Apoptotic cells inhibit LPS-induced cytokine and chemokine production and IFN responses in macrophages. Hum. Immunol. 68: 156-164.
46. Murdoch, C., S. Tazzyman, S. Webster, and C. E. Lewis. 2007. Expression of Tie-2 by human monocytes and their responses to angiopoietin-2. J. Immunol. 178: 7405-7411.
47. Jeon, B. H., F. Khanday, S. Deshpande, A. Haile, M. Ozaki, and K. Irani. 2003. Tie-ing the antiinflammatory effect of angiopoietin-1 to inhibition of NF-κB. Circ. Res. 92: 586-588.
48. Hatanaka, H., Y. Abe, M. Naruke, T. Tokunaga, Y. Oshika, T. Kawakami, H. Osada, J. Nagata, J. Kamochi, T. Tsuchida, et al. 2001. Significant correlation between interleukin 10 expression and vascularization through angiopoietin/TIE2 networks in non-small cell lung cancer. Clin. Cancer Res. 7: 1287-1292.
49. Chang, E. Y., B. Guo, S. E. Doyle, and G. Cheng. 2007. Cutting edge: involvement of the type I IFN production and signaling pathway in lipopolysaccharide-induced IL-10 production. J. Immunol. 178: 6705-6709.
50. Kaplan, D. H., V. Shankaran, A. S. Dighe, E. Stockert, M. Aguet, L. J. Old, and R. D. Schreiber. 1998. Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice. Proc. Natl. Acad. Sci. USA 95: 7556-7561.
51. Korherr, C., H. Gille, R. Schafer, K. Koenig-Hoffmann, J. Dixelius, K. A. Egland, I. Pastan, and U. Brinkmann. 2006. Identification of proangiogenic genes and pathways by high-throughput functional genomics: TBK1 and the IRF3 pathway. Proc. Natl. Acad. Sci. USA 103: 4240-4245.
52. Strieter, R. M., M. D. Burdick, J. Mestas, B. Gomperts, M. P. Keane, and J. A. Belperio. 2006. Cancer CXC chemokine networks and tumour angiogenesis. Eur. J. Cancer 42: 768-778.
53. Murdoch, C., and C. E. Lewis. 2005. Macrophage migration and gene expression in response to tumor hypoxia. Int. J. Cancer. 117: 701-708.
54. Cramer, T., Y. Yamanishi, B. E. Clausen, I. Forster, R. Pawlinski, N. Mackman, V. H. Haase, R. Jaenisch, M. Corr, V. Nizet, et al. 2003. HIF-1α is essential for myeloid cell-mediated inflammation. Cell 112: 645-657.
55. He, W., M. Qiang, W. Ma, A. J. Valente, M. P. Quinones, W. Wang, R. L. Reddick, Q. Xiao, S. S. Ahuja, R. A. Clark, et al. 2006. Development of a synthetic promoter for macrophage gene therapy. Human Gene Ther. 17: 949-959.
56. Guiducci, C., A. P. Vicari, S. Sangaletti, G. Trinchieri, and M. P. Colombo. 2005. Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection. Cancer Res. 65: 3437-3446.
57. Murdoch, C., A. Giannoudis, and C. E. Lewis. 2004. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 104: 2224-2234.
58. + myeloid cells. Nat. Biotechnol. 25: 911-920.
59. Fischer, C., B. Jonckx, M. Mazzone, S. Zacchigna, S. Loges, L. Pattarini, E. Chorianopoulos, L. Liesenborghs, M. Koch, M. De Mol, M. Autiero, et al. 2007. Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels. Cell 131: 463-475.
60. Li, F., P. Sonveaux, Z. N. Rabbani, S. Liu, B. Yan, Q. Huang, Z. Vujaskovic, M. W. Dewhirst, and C. Y. Li. 2007. Regulation of HIF-1α stability through S-nitrosylation. Mol. Cell 26: 63-74.